Tazpure-Beta 25 Tablet ER
Marketer
Arrient Healthcare Pvt Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Tazpure-Beta 25 Tablet ER
Beta-25 Extended Release tablets (Tazpure-brand) manage hypertension, reducing the risk of stroke and heart attack. Early use improves heart attack survival rates. Consistent blood levels are achieved by taking this medication with food daily, as directed by your physician. Continue treatment as prescribed; high blood pressure is often asymptomatic, so self-discontinuation is dangerous. Lifestyle modifications, including diet, exercise, and weight management, are beneficial. Always follow your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (possibly with fainting), shortness of breath, nausea, vomiting, abdominal pain, fatigue, and elevated potassium. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular blood pressure, blood sugar, kidney function, urea, and electrolyte monitoring may be necessary. Inform your doctor of any kidney or liver issues before starting treatment. Pregnant or breastfeeding individuals should seek medical advice prior to use. Disclose all other medications, particularly those for heart or blood pressure conditions.
Uses of Tazpure-Beta 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Tazpure-Beta 25 Tablet ER:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Tazpure-Beta 25 Tablet ER with a meal.
Common Side effects of Tazpure-Beta 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Tazpure-Beta 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Tazpure-Beta 25 Extended-Release tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with food.
How Tazpure-Beta 25 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Tazpure-Beta 25 ER tablets, provide a dual approach to hypertension management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Tazpure-Beta 25 ER tablets and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Tazpure-Beta 25 tablets pose a confirmed risk to a fetus; therefore, their use during pregnancy is contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Tazpure-Beta 25 tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Tazpure-Beta 25 tablets can cause drowsiness, blurred vision, and dizziness. Driving is inadvisable if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Tazpure-Beta 25 tablets are considered safe for patients with impaired renal function. No dosage modification is necessary for this medication in such individuals.
LiverCAUTION
Patients with hepatic impairment should use Tazpure-Beta 25 Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tazpure-Beta 25 Tablet ER :
Should you forget a dose of Tazpure-Beta 25 Tablet ER, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Tazpure-Beta 25 Tablet ER
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Heart-related |
3,018 People bought this recently